Affirm Holdings $1.39 billion IPO
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Atara Biotherapeutics $175 million common stock and pre-funded warrants offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…
Uber Technologies $1.15 billion convertible notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Uber Technologies, Inc. of $1.15 billion aggregate principal amount of its 0% convertible senior notes…
RAPT Therapeutics $100 million at-the-market offering
Davis Polk advised the sales agents on the SEC-registered at-the-market offering by RAPT Therapeutics, Inc. of its common stock for up to an aggregate amount of $100 million.
RAPT…
Revance Therapeutics $125 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Revance Therapeutics, Inc. of its common stock for up to an aggregate amount of $125 million.
Based…
GoPro $143.75 million convertible senior notes offering
Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by GoPro, Inc. of $143.75 million aggregate principal amount of 1.250% convertible senior notes due…
Kodiak Sciences $645 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $645.0 million public offering of 5,972,222 shares of common stock by…
Five Prime Therapeutics $173 million follow-on offering
Davis Polk advised the joint-bookrunning managers and representatives of the several underwriters in connection with an approximately $173.8 million public offering of common stock by…
Turning Point Therapeutics $460 million stock offering
Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…
Equinix bond offering, including $1.35 billion in inaugural green bonds
Davis Polk advised Equinix, Inc. on an SEC-registered offering of $1.85 billion aggregate principal amount of senior notes. The offering consisted of $700 million aggregate principal amount…